Xu Cheryl's Form 4 filing
60 Degrees Pharmaceuticals, Inc. (SXTP) · filed Dec 18, 2024
- Accession no.
- 0001213900-24-110269
- Filed
- Dec 18, 2024
- Trade date
- Dec 12-16, 2024
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions. Open-market purchases total $21.4K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Xu CherylCIK 0001976957 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | Common Stock | PPurchaseAcquired | +2,500 | $1.85 | +$4,625 | 43,578 | Direct | |
| Dec 12, 2024 | Common Stock | PPurchaseAcquired | +2,500 | $1.80 | +$4,500 | 46,078 | Direct | |
| Dec 13, 2024 | Common Stock | PPurchaseAcquired | +1,500 | $1.60 | +$2,400 | 47,578 | Direct | |
| Dec 13, 2024 | Common Stock | PPurchaseAcquired | +1,500 | $1.58 | +$2,370 | 49,078 | Direct | |
| Dec 13, 2024 | Common Stock | PPurchaseAcquired | +1,500 | $1.55 | +$2,325 | 50,578 | Direct | |
| Dec 13, 2024 | Common Stock | PPurchaseAcquired | +1,500 | $1.52 | +$2,280 | 52,078 | Direct | |
| Dec 16, 2024 | Common Stock | PPurchaseAcquired | +2,000 | $1.45 | +$2,900 | 54,078 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.